• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Pediatr . Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in th

tetano

Editor, Senior Moderator
Eur J Pediatr


. 2022 Aug 20.
doi: 10.1007/s00431-022-04593-7. Online ahead of print.
Nationwide observational study of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the Czech Republic


Jan David[SUP] #[/SUP][SUP] 1 [/SUP], Veronika Stara[SUP] #[/SUP][SUP] 2 [/SUP], Ondrej Hradsky[SUP] #[/SUP][SUP] 2 [/SUP], Jana Tuckova[SUP] 3 [/SUP], Katerina Slaba[SUP] 3 [/SUP], Petr Jabandziev[SUP] 3 4 [/SUP], Lumir Sasek[SUP] 5 [/SUP], Michal Huml[SUP] 5 [/SUP], Iveta Zidkova[SUP] 6 [/SUP], Jan Pavlicek[SUP] 6 [/SUP], Alzbeta Palatova[SUP] 7 [/SUP], Eva Klaskova[SUP] 7 [/SUP], Karina Banszka[SUP] 8 [/SUP], Eva Terifajova[SUP] 8 [/SUP], Radim Vyhnanek[SUP] 9 [/SUP], Marketa Bloomfield[SUP] 9 10 [/SUP], Sarka Fingerhutova[SUP] 11 [/SUP], Pavla Dolezalova[SUP] 11 [/SUP], Lucie Prochazkova[SUP] 12 [/SUP], Gabriela Chramostova[SUP] 13 [/SUP], Filip Fencl[SUP] #[/SUP][SUP] 2 [/SUP], Jan Lebl[SUP] #[/SUP][SUP] 2 [/SUP]



Affiliations

Abstract

The worldwide outbreak of the novel 2019 coronavirus disease (COVID-19) has led to recognition of a new immunopathological condition: paediatric inflammatory multisystem syndrome (PIMS-TS). The Czech Republic (CZ) suffered from one of the highest incidences of individuals who tested positive during pandemic waves. The aim of this study was to analyse epidemiological, clinical, and laboratory characteristics of all cases of paediatric inflammatory multisystem syndrome (PIMS-TS) in the Czech Republic (CZ) and their predictors of severe course. We performed a retrospective-prospective nationwide observational study based on patients hospitalised with PIMS-TS in CZ between 1 November 2020 and 31 May 2021. The anonymised data of patients were abstracted from medical record review. Using the inclusion criteria according to World Health Organization definition, 207 patients with PIMS-TS were enrolled in this study. The incidence of PIMS-TS out of all SARS-CoV-2-positive children was 0.9:1,000. The estimated delay between the occurrence of PIMS-TS and the COVID-19 pandemic wave was 3 weeks. The significant initial predictors of myocardial dysfunction included mainly cardiovascular signs (hypotension, oedema, oliguria/anuria, and prolonged capillary refill). During follow-up, most patients (98.8%) had normal cardiac function, with no residual findings. No fatal cases were reported.Conclusions: A 3-week interval in combination with incidence of COVID-19 could help increase pre-test probability of PIMS-TS during pandemic waves in the suspected cases. Although the parameters of the models do not allow one to completely divide patients into high and low risk groups, knowing the most important predictors surely could help clinical management.

Keywords: COVID-19; Incidence; MIS-C; Myocardial dysfunction; Predictors; Severe outcome.
 
Back
Top Bottom